Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. (NY: SNY )

43.41 USD UNCHANGED
Last Price Updated: 5:16 PM EST, Dec 31, 2018 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 43.41
Bid (Size) 43.00 (2)
Ask (Size) 45.15 (2)
Prev. Close 43.41
Today's Range 43.41 - 43.41
52wk Range N/A - N/A
Shares Outstanding 2,478,367,994
Dividend Yield 4.29%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sanofi and the Parkinson's Foundation collaborate to advance the availability of free genetic testing and counseling for people with Parkinson's disease
* $1 million in research funding to support PD GENEration, a first-of-its-kind national study offering free genetic testing and counseling for people with Parkinson's disease (PD) 
From PR Newswire
A Look Into Healthcare Sector Value Stocks
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. ... 
Tags General SNY Health Care
From Benzinga

Performance

More News

Read More
EmergingGrowth.com Reports on Why Galectin Therapeutics (GALT) is Due for a COVID-19 Makeover
Tags banking/finance/investment c:united/states travel/tourism
From EIN Presswire
Big Pharma's Vaccine Race – A Chance For Redemption
Tags INO JNJ Biotech
From Benzinga
World Bank Approves $12B Financing To Ensure Developing Countries Aren't Deprived Of COVID-19 Vaccine
Tags Health Care JNJ Biotech
From Benzinga
A Peek Into The Markets: US Stock Futures Mixed; JPMorgan, Citigroup Earnings In Focus
Tags C JNJ REGN
From Benzinga
Sanofi, Regeneron Report Positive Phase 3 Results For Asthma Drug Dupixent's Use In Children
Tags REGN Health Care Biotech
From Benzinga
EmergingGrowth.com Reports on Why Galectin Therapeutics is Due for a COVID-19 Makeover
Tags English IPS iCN Internal Distribution
From iCrowdNewswire
Sanofi, Translate Bio Post Positive Early Covid-19 Vaccine Results; Plan Human Testing
From Investor's Business Daily
Moderna, Pfizer Have 2-Month Lead Over Coronavirus Vaccine Competitors: Analyst
Tags Market News SVB Leerink MRNA
From Benzinga
Forget Snowflake! Buy This Ultra-High-Growth Stock
Tags SNOW EBS VXRT
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]